ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AOR Aortech International Plc

126.50
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Aortech International Plc LSE:AOR London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 126.50 123.00 130.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Aortech Share Discussion Threads

Showing 8026 to 8047 of 8900 messages
Chat Pages: Latest  332  331  330  329  328  327  326  325  324  323  322  321  Older
DateSubjectAuthorDiscuss
27/10/2019
17:49
Aortech relaunched itself with the equity issue at 30p last year, they have been quietly laying the foundations for a scalable medical device business utilizing an expert board and world class partners. The news flow over the next year should be fascinating and a £50m market cap should not be an unrealistic target.
landy90
27/10/2019
17:21
I hope some people understand that investing is much more complicated than they had initially expected.

I do not feel sorry for those who sold too soon. They are now hoping the share price falls so they can get in cheaper.

TMK

tees maar khan
27/10/2019
17:04
wow 78p bones

I last looked in and it was around 46p offer, I hope you put your msys losses here and got your money back.

dave4545
27/10/2019
16:57
Biomerics LLC, which has recently and usefully tweeted about its pride in being a partner of Aortech, is Aortech’s licensed manufacturer of its specialist polymers, Elasteon and ECSil. Biomerics is based in Utah, USA, where their multi-million dollar new HQ was constructed. That building has just been recognised for architectural quality:



From Aortech’s perspective, potential future bigger scale partners and distributors should be very comforted by the investment that Biomerics has made in its own infrastructure and, by extension, that of Aortech’s.

bones
27/10/2019
14:54
The lack of noise on Twitter is being addressed
the stigologist
26/10/2019
22:33
Been in this since mid-June last year. Have been mostly reading other people's input and not really felt the need to comment.

This company is undervalued by a country mile and looks like the traders are exhausted, sad and bored? Plenty of cautionary tales on AIM in these tough markets.

It's hard to resist the urge to post, especially after seeing the share price fly over the past couple of trading sessions. There is no noise surrounding AorTech on Twitter which can only be a good thing.

Onwards and upwards!

TMK

tees maar khan
26/10/2019
13:53
Stay long..I am.
blueball
26/10/2019
12:41
I've also stuck with it despite having seen its decline from July 2018 onwards. The fundamentals are right, but as you say markets are funny things.
ivor hunch
26/10/2019
06:47
I'm still here tooAmazed (but genuinely pleased) that the market hasn't noticed this one, cos if it did the board would be full of quick buck merchants and we could do without those.....imo
herschel k
25/10/2019
21:37
Good chart. Looks like a break out of 52 week highs on Closing basis.

Re Fundamentals now the Overhang has gone we should be looking at the historic invested capital of c.60m as a starting point for any serious revaluation here so around the Broker's 400p target really.

the stigologist
25/10/2019
17:40
Yes, and arguably the breakout has a long way to run to really BREAK OUT! Given what the company has achieved in less than 2 years and should command way more value now than in mid 2018, this breakout should be just starting. Markets are strange animals though!


free stock charts from uk.advfn.com

bones
25/10/2019
17:21
Idiot. [Double post]
the stigologist
25/10/2019
17:21
Finished just below 52 week high of 78.50 but its breaking out anyway so only a matter of time at this rate.
the stigologist
25/10/2019
16:08
I reckon that last trade was a buy rather than as shows in red?
coolhandfluke
25/10/2019
13:54
Amen to that, langland.
bones
25/10/2019
13:07
My earlier post was a little bit tongue in cheek but well done everyone for taking the trouble to respond. So far this month aor is up about 70% and no one has noticed -it seems. And we are still not much more than a 10mn mkt. cap. This seems plainly ridiculous when one of my old favourites AGL has a 135mn mkt. cap. and is still loss making and has to be supported by placings every so often. The potential here may not be as big as AGL but I certainly think there is scope for us to become 50-100mn within the next 2 years. Like another poster here I was intrigued that Biomerics tweeted last week. After about 5 years of being associated with aor why tweet now?
langland
25/10/2019
10:47
langland: I'm still here and appreciating the comments on the board. The points I would have made following the trading update were made by others although I also appreciate Aor's prudent cash management. Interesting that Aor have tied their potential success of polymer valves to one of their competitors:

AorTech has noted the progress made by certain former employees in achieving "first in man" with a polymer valve. We view this development positively, as a regulatory pathway has now been established for polymeric valves and testing protocols agreed. This provides us with confidence that our valve will have similar success, especially as a result of the recent improvements in design referred to above.

Look forward to the update in a month from now.

cfb2
25/10/2019
10:25
Absolutely, Net, and if the polymeric valve becomes the de facto standard (as it surely will on cost grounds alone as well as its multi-faceted advantages over current technologies), the market extends not only to the ever-expanding older populations in developed nations but also to hitherto deprived regions of poorer populations where there is a desperate need in younger people (AOR has already cited India where many children develop diseases that lead to heart valve failures before the 30th birthday of many of the afflicted).

The expense and need for ongoing medication means that current remedies are out of reach of vast numbers of people. Robotically produced polymeric valves will be vastly cheaper to produce than hand-stitched animal tissue models of today and should require far less medical maintenance in the way of drugs and hospital visits. The only question then will be... are there enough qualified surgeons?!

bones
25/10/2019
10:14
I'm still here, but dont know much about hearts.

I do know hearts wear out a great deal as we age. So the market is massive as Baby Boomers the world over are retiring in ever larger numbers every year and lots of them have lots of money.

netcurtains
25/10/2019
10:02
Ha! Long may it stay that way until the share price is at least a few quid.
bones
25/10/2019
09:35
Yes, bones, I thought I should put that vital piece of information on here since I figured it must be my turn to post something since there are only about half a dozen or so of us left here!
langland
25/10/2019
09:17
I see the seller today of 5,143 shares at 73.5 is likely to be the same person that bought 5,143 yesterday at 75.

Discuss.

Edit: crossed with your post Langland!

bones
Chat Pages: Latest  332  331  330  329  328  327  326  325  324  323  322  321  Older

Your Recent History

Delayed Upgrade Clock